The BCR–ABL1 fusion gene is the primary pathogenic driver of chronic myeloid leukaemia (CML) and also characterizes a subset of patients with acute lymphoblastic leukaemia. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.